Phase I trial of XOMA 358 in healthy volunteers.

Trial Profile

Phase I trial of XOMA 358 in healthy volunteers.

Phase of Trial: Phase I

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs XOMA 358 (Primary)
  • Indications Hyperinsulinaemia; Hypoglycaemia; Insulinoma
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Sponsors XOMA
  • Most Recent Events

    • 15 Sep 2016 According to XOMA media release, updates from this and other three studies of XOMA-358 were presented in a webcast on 15 Sep 2016.
    • 11 Mar 2015 Status changed from recruiting to completed, according to a XOMA Corporation media release.
    • 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top